Document is current
Any future updates will be listed below
-
Authors
Lopez, Ivan https://orcid.org/0000-0003-0246-2180
Swaminathan, Akshay https://orcid.org/0000-0003-3426-9289
Vedula, Karthik
Narayanan, Sanjana
Nateghi Haredasht, Fateme
Ma, Stephen P. https://orcid.org/0000-0003-3738-9569
Liang, April S.
Tate, Steven
Maddali, Manoj
Gallo, Robert Joseph https://orcid.org/0000-0002-2601-0173
Shah, Nigam H. https://orcid.org/0000-0001-9385-7158
Chen, Jonathan H. https://orcid.org/0000-0002-4387-8740
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (1R01AI17812101)
- License Information
-
More Information
Article History
Received: 1 July 2024
Accepted: 8 December 2024
First Online: 19 January 2025
Competing interests
: A.S. owns stock in Roche (RHHVF) and Cerebral Inc. and is an adviser to Daybreak Health and Cerebral Inc. S.N. owns stock in Meta, works at Insitro (an ML for drug discovery company), and owns stock options for Insitro. N.H.S. reported being a co-founder of Prealize Health (a predictive analytics company) and Atropos Health (an on-demand evidence generation company); receiving funding from the Gordon and Betty Moore Foundation for developing virtual model deployments; and serving on the Board of the Coalition for Healthcare AI (CHAI), a consensus-building organization providing guidelines for the responsible use of artificial intelligence in healthcare. J.H.C. reported being a co-founder of Reaction Explorer LLC, develops and licenses organic chemistry education software, paid consulting fees from Sutton Pierce, Younker Hyde MacFarlane, and Sykes McAllister as a medical expert witness, and paid consulting fees from ISHI Health. The remaining authors declare no competing interests.
